Your browser doesn't support javascript.
loading
The SELFI Study: Iodine Excess and Thyroid Dysfunction in Women Undergoing Oil-Soluble Contrast Hysterosalpingography.
Mathews, Divya M; Peart, Jane M; Sim, Robert G; Johnson, Neil P; O'Sullivan, Susannah; Derraik, José G B; Hofman, Paul L.
Afiliação
  • Mathews DM; Liggins Institute, University of Auckland, Auckland 1142, New Zealand.
  • Peart JM; Department of Radiology, Auckland Radiology Group, Auckland 1050, New Zealand.
  • Sim RG; Department of Radiology, Auckland Radiology Group, Auckland 1050, New Zealand.
  • Johnson NP; Department of Obstetrics and Gynecology, Robinson Research Institute, University of Adelaide, Adelaide, South Australia 5006, Australia.
  • O'Sullivan S; Department of Reproductive Endocrinology and Fertility, Repromed Auckland and Auckland Gynecology Group, Auckland 1050, New Zealand.
  • Derraik JGB; Department of Endocrinology, Greenlane Clinical Centre, Auckland District Health Board, Auckland 1051, New Zealand.
  • Hofman PL; Liggins Institute, University of Auckland, Auckland 1142, New Zealand.
J Clin Endocrinol Metab ; 107(12): 3252-3260, 2022 11 25.
Article em En | MEDLINE | ID: mdl-36124847
ABSTRACT
CONTEXT Hysterosalpingography (HSG) with oil-soluble contrast medium (OSCM) improves pregnancy rates. However, OSCM has high iodine content and long half-life, leading to potential iodine excess.

OBJECTIVE:

This work aimed to determine the pattern of iodine excess after OSCM HSG and the effect on thyroid function.

METHODS:

A prospective cohort study was conducted of 196 consecutive consenting eligible women without overt hypothyroidism or hyperthyroidism. All completed the study with compliance greater than 95%. Participants underwent OSCM HSG (Auckland, 2019-2021) with serial monitoring of thyrotropin (TSH), free thyroxine (FT4), and urine iodine concentration (UIC) for 24 weeks. The main outcome measure was the development of subclinical hypothyroidism (SCH), defined as a nonpregnant TSH greater than 4 mIU/L with normal FT4 (11-22 pmol/L) in those with normal baseline thyroid function.

RESULTS:

Iodine excess (UIC ≥ 300 µg/L) was almost universal (98%) with UIC peaking usually by 4 weeks. There was marked iodine excess, with 90% and 17% of participants having UIC greater than or equal to 1000 µg/L and greater than 10 000 µg/L, respectively. Iodine excess was prolonged with 67% having a UIC greater than or equal to 1000 µg/L for at least 3 months. SCH developed in 38%; the majority (96%) were mild (TSH 4-10 mIU/L) and most developed SCH by week 4 (75%). Three participants met the current treatment guidelines (TSH > 10 mIU/L). Thyroxine treatment of mild SCH tended to improve pregnancy success (P = .063). Hyperthyroidism (TSH < 0.3 mIU/L) occurred in 9 participants (5%).

CONCLUSION:

OSCM HSG resulted in marked and prolonged iodine excess. SCH occurred frequently with late-onset hyperthyroidism occasionally. Regular thyroid function tests are required for 6 months following this procedure.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças da Glândula Tireoide / Hipertireoidismo / Hipotireoidismo / Iodo Tipo de estudo: Guideline / Observational_studies Limite: Female / Humans / Pregnancy Idioma: En Revista: J Clin Endocrinol Metab Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Nova Zelândia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças da Glândula Tireoide / Hipertireoidismo / Hipotireoidismo / Iodo Tipo de estudo: Guideline / Observational_studies Limite: Female / Humans / Pregnancy Idioma: En Revista: J Clin Endocrinol Metab Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Nova Zelândia